IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,632,332 | +12.3% | 273,347 | +24.1% | 0.01% | +12.5% |
Q2 2023 | $2,342,981 | +10.7% | 220,205 | +9.5% | 0.01% | 0.0% |
Q1 2023 | $2,116,098 | -15.1% | 201,150 | 0.0% | 0.01% | -11.1% |
Q4 2022 | $2,492,249 | +12.9% | 201,150 | -5.6% | 0.01% | 0.0% |
Q3 2022 | $2,207,000 | -4.0% | 213,014 | +6.8% | 0.01% | 0.0% |
Q2 2022 | $2,300,000 | -21.4% | 199,448 | -14.2% | 0.01% | 0.0% |
Q1 2022 | $2,925,000 | +10.6% | 232,492 | +14.8% | 0.01% | +12.5% |
Q3 2021 | $2,645,000 | -0.8% | 202,526 | -2.3% | 0.01% | -11.1% |
Q2 2021 | $2,667,000 | +2.5% | 207,193 | -10.9% | 0.01% | 0.0% |
Q1 2021 | $2,601,000 | +5.4% | 232,635 | +7.4% | 0.01% | 0.0% |
Q4 2020 | $2,468,000 | +24.2% | 216,692 | -1.9% | 0.01% | +12.5% |
Q3 2020 | $1,987,000 | +12.1% | 220,860 | +28.6% | 0.01% | +14.3% |
Q2 2020 | $1,772,000 | -9.1% | 171,746 | -11.1% | 0.01% | -22.2% |
Q1 2020 | $1,949,000 | -24.2% | 193,182 | 0.0% | 0.01% | -10.0% |
Q4 2019 | $2,571,000 | +36.2% | 193,182 | -12.2% | 0.01% | +42.9% |
Q3 2019 | $1,888,000 | – | 219,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $172,422,800 | 22.05% |
13D Management LLC | 533,562 | $5,613,073 | 2.85% |
Quantedge Capital Pte Ltd | 541,200 | $5,693,424 | 2.22% |
Price Jennifer C. | 520,000 | $5,470,400 | 1.74% |
Tamarack Advisers, LP | 210,000 | $2,209,200 | 0.81% |
Intrinsic Value Partners, LLC | 51,605 | $542,885 | 0.73% |
Brown Capital Management | 3,933,933 | $41,384,975 | 0.62% |
Old West Investment Management, LLC | 75,219 | $791,303 | 0.43% |
EMC Capital Management | 43,315 | $456 | 0.38% |
Hillsdale Investment Management Inc. | 420,617 | $4,424,891 | 0.38% |